Mayo Clinic Talks

Host: Darryl S. Chutka, M.D.  Guest: Stephen Ansell, M.D., Ph.D.  Non-Hodgkin’s Lymphoma is a group of hematologic malignancies originating in the lymphatic system. There are over 60 subtypes of lymphoma with varying degrees of aggressiveness. It can present with a variety of rather subtle symptoms, often making the diagnosis challenging. Although Non-Hodgkin’s Lymphoma is typically managed by a hematologist or oncologist, the primary care provider plays a role in its recognition, preliminary diagnostic tests and supporting patients through their treatment. What are some of the more common symptoms and signs of Non-Hodgkin’s Lymphoma? Which ones should prompt an urgent referral, and what preliminary tests should we do prior to referring the patient? These are some of the questions I’ll be asking my guest, Dr. Stephen Ansell, Chair of the Division of Hematology at the Mayo Clinic. The topic for this podcast is Non-Hodgkin’s Lymphoma.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Host: Darryl S. Chutka, M.D.  Guest: Stephen Ansell, M.D., Ph.D.  Hodgkin’s Lymphoma is an uncommon but very curable malignancy involving the lymphatic system. It most commonly presents in young adults as well as middle-aged and older individuals. Although Hodgkin’s is generally managed by hematologists or oncologists, the primary care provider plays a major role in its recognition, hopefully leading to a timely diagnosis and eventual staging. What are some early signs of Hodgkin’s and what preliminary work-up should we do prior to referring the patient for definitive care? How do we monitor those who have had successful treatment of Hodgkin’s? These are some of the questions I’ll be asking my guest, Dr. Stephen Ansell, Chair of the Division of Hematology at the Mayo Clinic as we discuss Hodgkin’s Lymphoma.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Host: Darryl S. Chutka, M.D.  Guests: Jae K. Oh, M.D., Tahir S. Kafil, M.D.  Diastolic heart failure is also known as heart failure with preserved ejection fraction. Although we don’t hear the term all that often, it actually represents a fairly large percentage of all cases of heart failure. Some studies suggest it represents the majority of heart failure cases. Older adults are most commonly affected with symptoms similar to those of systolic heart failure. So how do we suspect diastolic heart failure? How should the diagnosis be established, and how does the treatment differ from systolic heart failure? Finally, what role do primary care providers play in the management of the condition? These are some of the questions I’ll be asking my guests, Dr. Jae Oh and Dr. Tahir Kafil, both cardiologists in the Department of Cardiovascular Disease at the Mayo Clinic as we discuss “Diastolic Heart Failure”.   Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Host: Darryl S. Chutka, M.D.  Guest: Balaji Tamarappoo, M.D., Ph.D.  With advances in oncology, patients are living longer than ever following a diagnosis of cancer. Newer treatments have dramatically improved survival. However, we’re also seeing an increasing number of cancer survivors who are at risk for cardiovascular complications; at times during treatment, and sometimes years later. Complications such as heart failure, cardiac arrhythmias, hypertension, and accelerated coronary disease are not uncommonly seen in our primary care practice.  As primary care clinicians, what do we need to know? I’m joined today by Dr. Balaji Tamarappoo, M.D., Ph.D., a cardiologist with expertise in cardio-oncology. We’ll discuss which cancer therapies pose the highest cardiac risks, what baseline and surveillance testing is recommended, if the risk of cardiotoxicity be decreased, and how primary care can partner effectively with oncology and cardiology to protect our patients’ hearts while they battle their malignancy. The topic for today’s podcast is “Cardiotoxicity of Cancer Therapies.”  Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Host: Darryl S. Chutka, M.D.  Guest: Hema Narayanasamy, M.B.B.S.  Pericardial disease represents a spectrum of both inflammatory and non-inflammatory disorders which involve the pericardium, with acute pericarditis being the most common disorder. Although not often seen in a primary care practice, we still need to consider pericarditis as it can masquerade several other more commonly seen conditions. It’s important to recognize pericardial disease early and decide who needs an urgent referral or hospitalization for appropriate treatment. What are some of the more common causes of pericardial disease? What are the most commonly encountered symptoms, physical exam findings, imaging results, and lab abnormalities? What are the potential complications? The topic for today’s podcast is pericardial disease, and my guest is Dr. Hema Narayanasamy, from the Department of Cardiovascular Disease from the Arizona campus of the Mayo Clinic.  Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Host: Darryl S. Chutka, M.D.  Guest: Stephen Kopecky, M.D.  We have a variety of pharmacologic options and lifestyle changes we recommend to our patients to reduce their cardiovascular risks. One frequent recommendation is participation in a regular exercise program. One specific type of exercise is high intensity interval training. It’s been shown to improve a variety of metabolic parameters. What does high intensity interval training consist of? What are the specific metabolic benefits? Can all patients participate in this type of exercise? What’s the recommended duration and frequency of training and how good is patient adherence to interval training? The topic for this podcast is “High Intensity Interval Training and Reducing Cardiovascular Risk” and my guest is Dr. Stephen Kopecky, a preventive cardiologist in the Department of Cardiovascular Disease at the Mayo Clinic.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Host: Darryl S. Chutka, M.D.  Guest: George Wang, M.D.  Bicuspid aortic valve is a relatively common congenital heart disease. It can be associated with other genetic disorders such as Turner’s Syndrome or exist as an isolated entity. In most cases, patients with a bicuspid aortic valve are initially asymptomatic; however later in the course, they may develop symptoms related to a subsequent aortic stenosis or regurgitation. It’s also associated with a dilated ascending aorta with potential rupture if unrecognized. Therefore, it’s in the patient’s best interest to diagnose the condition as early as possible. What are the early symptoms and when should we suspect the patient may have a bicuspid aortic valve? What type of surveillance should be performed and when is surgery indicated? These are some of the questions I’ll be asking my guest, Dr. George Wang, a cardiologist in the Department of Cardiovascular Medicine at the Arizona Campus of the Mayo Clinic as we discuss “Bicuspid Aortic Valve Disease”.  Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Host: Darryl S. Chutka, M.D.  Guest: Julie Rosenthal, M.D.  Cardiac amyloidosis is not a common condition, but it is important for primary care clinicians to recognize it in our patients. It’s commonly underdiagnosed as the symptoms are often assumed to be due to other, more common cardiac problems. Early recognition is important since this can result in improved treatment options and better patient outcomes. So how do we recognize cardiac amyloidosis? What are the presenting symptoms and what’s the best way to establish an accurate diagnosis? I’ll be asking my guest these questions as we discuss cardiac amyloidosis. My guest for tis podcast is Dr. Julie Rosenthal, a cardiologist in the Department of Cardiovascular Medicine at the Arizona campus of the Mayo Clinic.   Mayo Clinic Talks: Heart Health | Mayo Clinic School of Continuous Professional Development  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

 Host: Darryl S. Chutka, M.D. Guest: Matthew B. Anastasi, M.D. Patients with concussions are commonly seen in primary care practices and concussions don’t spare any particular age group. Children, young adult athletes and older individuals are all at increased risk. They’re a form of traumatic brain injury and while most are self-limiting, they require an accurate assessment, proper management and appropriate follow-up to make sure the patient is recovering and not experiencing complications. When should we suspect a concussion? What questions should we be asking in order to make an accurate diagnosis? What’s the best management of a patient who has had a concussion and finally, when can that patient return to their normal activities? The topic for this podcast is “Concussions: What Every Primary Care Provider Should Know” and my guest is Dr. Matthew Anastasi, a family medicine and sports medicine physician at the Arizona campus of the Mayo Clinic. Learn more at https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D.  Guest: Stephen Kopecky, M.D.  One of the biggest surprises we’ve seen in medicine in the past several years has been the numerous health benefits realized from the GLP-1 agonists. Originally developed for the management of diabetes, they’ve shown significant potential to improve cardiovascular risks, beyond controlling blood glucose and lowering hemoglobin A1c. Several studies have shown reductions in cardiovascular events including MI, stroke as well as reducing overall cardiovascular death. What is the mechanism of action for these cardiovascular benefits? Are there any differences in the various GLP-1 medications available and who’s a candidate for a GLP-1 medication? I’ll get answers to all of these questions and more in this podcast as I speak with Dr. Stephen Kopecky, a preventive cardiologist at the Mayo Clinic. We’ll be discussing “GLP-1 Agonists and Reducing Cardiovascular Risk”.  Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development  Learn more at https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D.  Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B.  The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially indicated for management of diabetes, they’re frequently taken for the weight loss they commonly produce. How long should these medications be taken? Is there anything we can do to help maintain the weight loss achieved with these medications? How significant is the loss of muscle mass which can occur as part of the weight lost with these medications and can this be minimized. Finally, how safe are the compounded and unapproved versions of these medications patients often find more affordable? These are a few of the questions we’ll address in podcast on the GLP-1 medications used for weight loss and we’ll tackle the “Controversies and Future of the GLP-1 Medications”. My guests include Dr. Meera Shah and Dr. Tamim Rajjo, both from the Division of Endocrinology at the Mayo Clinic.  Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development  Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D.  Guest: Tamim Rajjo, M.D., M.P.H.  Using GLP-1 medication for weight loss has become very popular with our patients. In the recent past, this has produced a shortage of these medications available, and those taking them for management of diabetes have found them difficult to obtain. Although in most cases, they are quite successful in producing substantial weight loss, many have regained weight after the medication was discontinued. How much weight can patients expect to lose with these medications? When should these medications be stopped, or should they? Are there strategies that have shown benefit to help patients maintain the weight they lose once the medication is discontinued? This podcast is the second of three on using the GLP-1 medications for weight loss and we’ll discuss “The Importance of Lifestyle Changes with the Use of GLP-1 Medications for Weight Loss”. My guest is Dr. Tamim Rajjo, a physician trained in Preventive Medicine and Obesity Medicine from the Mayo Clinic.  Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development  Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B. Using GLP-1 medications for weight loss has become extremely popular. Is this the latest fad in losing weight, or will these medications completely change our approach to managing obesity? They do appear to be very effective in promoting substantial weight loss. What is the history of these medications? Are there differences in the various GLP-1 medications available? What are the potential adverse effects of this drug class? This podcast is the first in a series of three on the GLP-1 medications prescribed for weight loss. The topic for this podcast is “Who Is a candidate for a GLP-1 Medication?” and my guests include Dr. Meera Shah and Dr. Tamim Rajjo, both from the Division of Endocrinology and Metabolism at the Mayo Clinic. Check out the series! Rx for Weight Loss: A Closer Look Series | Mayo Clinic School of Continuous Professional Development Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

WELCOME TO SEASON 6 OF THE MAYO CLINIC TALKS PODCAST! Host: Darryl S. Chutka, M.D. Guest: Warren G. Thompson, M.D. Alcohol can offer a variety of social and potential health benefits when consumed in moderation. However, alcohol is also associated with a variety of health risks, including addiction, increased likelihood of accidents, impaired judgment, cardiovascular problems, hepatic disease and even malignancy. Other than the social benefits, are there true health benefits of alcohol? Is there an amount of alcohol that’s considered safe? How can we as primary care clinicians convey the health risks of alcohol to our patients? The topic for this podcast is the “Risks and Benefits of Alcohol” and these are some of the questions I’ll be asking my guest, Warren G. Thompson, M.D., an internist and preventive medicine specialist at the Mayo Clinic. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts   

HAPPY HOLIDAYS! Enjoy this re-release from Season 3 of Mayo Clinic Talks: Host: Darryl S. Chutka, M.D.  Guest: Amy S. Oxentenko, M.D.   It’s estimated that less than 1/3 of individuals with celiac disease have been properly diagnosed. When those with celiac disease ingest gluten, an immune response develops which attacks the small intestine leading to inadequate absorption of nutrients. If left untreated, celiac disease can lead to a variety of nutritional deficiencies as well as other serious consequences. Those with celiac disease are also at increased risk for coronary disease and small bowel cancers. In this podcast we’ll review celiac disease and gluten sensitivity with our guest, Amy S. Oxentenko, M.D., a gastroenterologist at the Mayo Clinic. We’ll discuss the symptoms of celiac disease, how to diagnose the condition and how patients with celiac disease should be managed.   Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

HAPPY HOLIDAYS! Enjoy this re-release from Season 3 of Mayo Clinic Talks:   Host: Darryl S. Chutka M.D. Guest: Lisa Lammert, R.D.N., L.D.   Cardiovascular disease is the leading cause of death to individuals in the U.S. Many feel that our typical American diet with its high saturated fat content is a major contributor to this. There’s good evidence that shows plant-based diets are cost-effective in lowering the risk factors for cardiovascular disease including obesity, hyperlipidemia, hypertension, and diabetes. They may also lower the number of medications an individual needs to take to manage their chronic diseases. So, are there any disadvantages to a plant-based diet? Are all plant-based diets healthy and what are the nutritional challenges for a patient on a plant-based diet? We’ll discuss these questions in this podcast on “Plant-Based Diets”. Our guest is Lisa Lammert, a registered dietician and nutritionist at the Mayo Clinic.   Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guest: Cory Ingram, M.D. As primary care providers, we have the privilege of guiding our patients through their healthcare journey, healing their medical conditions, managing them through chronic illness and at times, assisting them through the final chapters of their life. The topic for today’s podcast is “Hospice”, an important though often underutilized part of that journey. Hospice is not about giving up, it’s about changing the direction and goal of our care from cure to comfort. It prioritizes quality of life and maintaining dignity for patients going through a very challenging period of their life. My guest is Cory Ingram, M.D., a family medicine and palliative care physician from the Mayo Clinic who has extensive experience and insight into this topic. He’ll guide us through when we should consider hospice, who qualifies for hospice and the importance of good communication skills in helping patients and their families during this last period of their life. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guest: Andrew R. Jagim, Ph.D. Nutritional supplements are very popular with our patients. They are supposed to provide benefits that may not be present in our typical diet. Vitamins and minerals are the most common supplements taken, followed closely by sports nutrition products such as protein powders and energy drinks. Consumers buy supplements because they’re readily available, relatively low cost and they believe that supplements will help them achieve health benefits. Patients often assume that supplements are safe, yet some can cause significant health problems, especially when taken in higher doses. Some have the potential to interact with various prescription medications. Are there nutritional supplements our patients should be taking? Which ones are potentially harmful? How safe are these products and do supplements have any regulatory oversight? These are questions I’ll be asking my guest, Andrew R. Jagim, Ph.D., Director of Sports Medicine Research at the Mayo Clinic as we discuss “Nutritional Supplements”. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guest: Cory Ingram, M.D. There are a couple outcomes in taking a medical history. Obviously, one is information gathering. You need to hear the patient’s symptoms to help form your differential diagnosis. The second, and equally important, is to help establish a relationship with that patient. There are several reasons a good provider-patient relationship is important. The patient is more likely to feel positive about their medical encounter, they’re more likely to be adherent to your recommendations regarding their health conditions, and they tend to be more forgiving if they experience an adverse event. What makes up a good provider-patient relationship? What can we do as clinicians to help establish a good relationship with our patients? Can we still establish a good relationship when we practice telemedicine? These are questions I’ll be asking my guest, Cory Ingram, M.D., a palliative care physician at the Mayo Clinic as we discuss “Provider-Patient Relationship Skills”. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guests: William J. Casey III, M.D. and Andrea L. Cheville, M.D. There are numerous reasons a patient may develop swelling of an extremity. One of the less common reasons, but often misdiagnosed or undiagnosed is lymphedema. What is lymphedema, why does it occur and who’s at risk for it? Early recognition is important to prevent complications and primary care providers play a crucial role in identifying patients with lymphedema, coordinating their care and providing follow-up. How can we differentiate lymphedema from other causes of swelling? What are the potential complications if lymphedema is not correctly diagnosed and finally, what are some of the latest treatments available for the management of lymphedema? The topic for this podcast is “Lymphedema: Challenges and Success” and my guests include Andrea L. Cheville, M.D., a physician in the Department of Physical Medicine and Rehabilitation and William J. Casey, III, M.D., a physician in the Department of Plastic Surgery, both at the Mayo Clinic. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts  To hear more about this series: https://ce.mayo.edu/content/mayo-clinic-talks-vascular-medicine-series